首页> 外文OA文献 >Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
【2h】

Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study

机译:没有明显甲状腺疾病的成人脂质和甲状腺功能试验的趋势:来自德黑兰甲状腺研究的群组

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ContextWhile the role of overt hypothyroidism in lipid disorders is clear, the association between dyslipidemia and subclinical thyroid diseases remains unclarified.ObjectiveTo examine lipid trends based on thyroid function over a 10-year period.DesignThis is a prospective population based cohort study.SettingGeneral community.Participants2383 euthyroid participants, as well as those with subclinical thyroid diseases, in all residents of district 13 of Tehran were examined. Subjects who were on levothyroxine, anti-hyperthyroid drugs, and glucocorticoids, those with a history of thyroid surgery or RAI and pregnant women were excluded.Main outcome measuresLipid trends in Model 1 were adjusted for age and follow up duration, and in Model 2 gender-specific multivariate adjustments were performed for thyroid status, diabetes mellitus, smoking status, education, BMI, lipid lowering medications, age and follow up duration by using generalized estimating equations.ResultsIn every four years of assessments, there were significant decreases in levels of all lipid parameters (all Ps <0.001) except for HDL-C, in which a decrescendo-crescendo trend was observed. The results did not change after adjusting for thyroid status, consumption of lipid lowering drugs during the follow-up period, or other variables. There were significant decreases in the prevalence of hypercholesterolemia and hypertriglyceridemia (all Ps <0.001) during the follow-up period.ConclusionDuring a 10 year follow-up, decrescendo trends were observed in levels of total cholesterol, triglycerides, which were not be accounted for by the consumption of lipid lowering drugs and thyroid status.
机译:ContextWhile甲状腺功能减退的脂质紊乱的作用是明确的,血脂异常和亚临床甲状腺疾病之间的关联仍然unclarified.ObjectiveTo研究基于在10年period.DesignThis甲状腺功能脂质趋势是基于队列study.SettingGeneral社区的前瞻性人群。 Participants2383甲状腺功能正常的参加者,以及那些有亚临床甲状腺疾病,检查德黑兰的13个区的所有居民。受试者谁是对甲状腺素,抗甲亢药,糖皮质激素,患有甲状腺手术或RAI和孕妇的病史是excluded.Main结果measuresLipid模型1的发展趋势进行了调整年龄和随访时间,并在型号2性别甲状腺状态,糖尿病,吸烟状况,教育,体重指数,降脂药物,年龄进行特异性多元的调整和后续使用广义估计equations.ResultsIn每四年评估的时间,有在所有水平显著下跌脂质参数(所有的PS <0.001)除HDL-C,其中观察到渐弱渐强的趋势。结果在随访期间,或其它变量调节甲状腺的状态,降脂药食用后并没有改变。有高胆固醇血症和高甘油三酯血症(所有的PS <0.001)的期间患病率显著下跌的后续period.ConclusionDuring 10年的随访中,总胆固醇,甘油三酯,这些都没有被占的水平,观察趋势渐弱通过降脂药和甲状腺状态的消耗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号